Limitations of Novel Drug Delivery System

In spite of having a huge freedom and advantages of NDDS, it also has some drawbacks and limitation. The administration and implementation cost of Nano medicine is much more expensive. Cytotoxicity of the nanoparticles also becomes a threat for future. Nano product facing greater problem due to their much higher cost and complexicity. The limited availability and lower production rate of personalized medicine & device is problematic for a large amount of user. Some innovative & noninvasive delivery improve the patient acceptance by lowering the marketed price & production cost. I.e. Why these results in the product degradation & quality issue.

Novel drugs which are administered through the oral cavity should possess the risk of undergoing acid or enzymatic degradation or hydrolysis. Some medical devices like Nano shell, Nano tube, Nano pores are difficult to administered into body of some patient, baby, or old people. All type of drugs or medicine cannot be administered  through the nanoparticles, carriers or devices because they cannot be incorporated in the polymer matric or they can be degraded. But the scientist and researchers are continuously try to overcome the drawbacks through their invention.

  • Barriers to drug delivery in tumors
  • Challenges and barriers of ocular drug delivery
  • Formulation design of poorly soluble drugs
  • Vegetative formulation
  • Pharmaceutical equipment & drug release testing
  • Academy & industry perspective

Related Conference of Limitations of Novel Drug Delivery System

September 25-26, 2019 Hong Kong

17th World Congress on Drug Formulation & Drug Delivery

Courtyard by Marriott Hong kong
October 07-08 2019

Global Congress on Pharmacology and Therapeutics

Paris, France
October 07-08, 2019

Innovation in Drug Design Techniques and pharmacology

| Paris, France
October 10-11, 2019

15th World Congress on Medicinal Chemistry & CADD

Dubrovnik | Croatia
October 14-15, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Seoul, South Korea
October 25-26, 2019

14th International Conference on Biopharma and Biotherapeutics

| Copenhagen, Denmark
October 23-24, 2019 | Copenhagen, Denmark

12th Pharma Congress

September 11-12, 2019

2nd Annual Pharmaceutical Biotechnology Congress

Singapore
November 11-12, 2019

20th Annual Pharma Middle East Congress

Istanbul, Turkey
November 18-19, 2019

European Congress on Nanomedicine and Pharmaceutical Nanotechnology

Prague, Czech Republic
November 18-19, 2019

European Conference on Pharmacovigilance & Drug Safety

Prague, Czech Republic
November 18-19, 2019

27th Global Experts Meeting on Neuropharmacology

Rome, Italy
November 19-20, 2019

20th Annual Meet on Pharmaceutical Sciences

Bangkok, Thailand
December 02-03, 2019

15th Annual Congress on Pharmacology and Toxicology

Paris, France
February 12-13, 2020

14th Global Pharmacovigilance and Clinical Trials Summit

Sydney, Australia
February 12-13, 2020

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, New Zealand
March 23- 24, 2020

14 th World Drug Delivery Summit

| Dublin, Ireland
March 25-26, 2020

23rd Asia Pacific Pharma Congress

Singapore
April 01-02, 2020

13th European Biosimilars Congress 2020

London, UK
April 09-10, 2020

World Pharma Expo

Bangkok, Thailand
April 27-28, 2020

5th Pharmaceutical Chemistry Conference

Prague, Czech Republic
April 27-28, 2020

7th European Biopharma Congress

Prague, Czech Republic
May 06-07, 2020

15th Annual Meet on Euro Ethnopharmacology

Prague | Czech Republic
May 18-19, 2020

30th Annual European Pharma Congress

Berlin, Germany
December 06-07, 2021

22nd Pharma Middle East Congress

Dubai, UAE

Limitations of Novel Drug Delivery System Conference Speakers

Recommended Sessions

Related Journals

Are you interested in